GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
8TUI | 8TUI | Crystal structure of Fab-Lirilumab bound to KIR2DL3 | |
8TUD | P0DOX5 | IgG1 Fc Heterodimer combYSelect2 | |
8TU9 | Q68CP4 | Cryo-EM structure of HGSNAT-acetyl-CoA complex at pH 7.5 | |
8TU9 | A0A9X4KGN5 | Cryo-EM structure of HGSNAT-acetyl-CoA complex at pH 7.5 | |
8TTZ | G8E2R2 | Crystal structure of monkey TLR7 ectodomain with compound 20 | |
8TTY | G8E2R2 | Crystal structure of monkey TLR7 ectodomain with compound 5 | |
8TTW | Q2N0S6 | Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 | |
8TTW | Q2N0S5 | Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 | |
8TTW | 8TTW | Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 | |
8TTM | P0DOX5 | IgG1 Fc Heterodimer combYSelect1 | |
8TSM | Q90922 | Crystal structure of chicken Netrin-1 LN LE1-2 | |
8TRR | P01903 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRR | P01911 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRR | P08670 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRR | 8TRR | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRQ | P01903 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRQ | P01911 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRQ | P08670 | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRQ | 8TRQ | T cell recognition of citrullinated vimentin peptide presented by HLA-DR4 | |
8TRL | P01903 | T cell recognition of citrullinated alpha-enolase peptide presented by HLA-DR4 | |
8TRL | P01911 | T cell recognition of citrullinated alpha-enolase peptide presented by HLA-DR4 | |
8TRL | 8TRL | T cell recognition of citrullinated alpha-enolase peptide presented by HLA-DR4 | |
8TRK | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist methyl blue | |
8TRJ | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the high-affinity agonist BzATP | |
8TRB | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist JNJ47965567 | |
8TRA | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist GSK1482160 | |
8TR8 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist AZD9056 | |
8TR7 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist A839977 | |
8TR6 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in complex with the allosteric antagonist A438079 | |
8TR5 | Q64663 | Cryo-EM structure of the rat P2X7 receptor in the apo closed state | |
8TR3 | D7S2E5 | Cryo-EM structure of HmAb64 scFv in complex with CNE40 SOSIP trimer | |
8TR3 | 8TR3 | Cryo-EM structure of HmAb64 scFv in complex with CNE40 SOSIP trimer | |
8TQS | P00734 | Complex of human thrombin (S195A) bound to a bivalent inhibitor comprised of DNA Aptamer HD22 conjugated to Dabigatran with a linker. | |
8TQA | P01899 | Crystal structure of Fab.28.14.8 in complex with MHC-I (H2-Db) | |
8TQA | P01887 | Crystal structure of Fab.28.14.8 in complex with MHC-I (H2-Db) | |
8TQA | 8TQA | Crystal structure of Fab.28.14.8 in complex with MHC-I (H2-Db) | |
8TQ1 | Q2N0S6 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
8TQ1 | Q2N0S5 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
8TQ1 | 8TQ1 | HIV-1 BG505 Env SOSIP in complex with bovine Fab Bess4 and non-human primate Fab RM20A3 | |
8TPA | Q6WG00 | H1 hemagglutinin (NC99) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TPA | 8TPA | H1 hemagglutinin (NC99) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TP9 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TP9 | 8TP9 | H2 hemagglutinin (A/Singapore/1/1957) in complex with medial-junction-targeting Fab 2-2-1G06 | |
8TP7 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with Sa-targeting Fab 4-1-1G03 | |
8TP7 | 8TP7 | H2 hemagglutinin (A/Singapore/1/1957) in complex with Sa-targeting Fab 4-1-1G03 | |
8TP6 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 4-1-1E02 | |
8TP6 | 8TP6 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 4-1-1E02 | |
8TP5 | Q6WG00 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1E04 | |
8TP5 | 8TP5 | H1 hemagglutinin (NC99) in complex with RBS-targeting Fab 1-1-1E04 | |
8TP4 | A3KF33 | H2 hemagglutinin (A/Singapore/1/1957) in complex with RBS-targeting Fab 1-1-1E04 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024